Skip to main content

Want a detailed portfolio tracker?

MiNK Therapeutics (INKT) Income Statement (2020 - 2026)

Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for MiNK Therapeutics (INKT).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020
Operating Expenses
Research And Development
1.20M
(-20.53%)
1.51M
(+32.46%)
1.14M
(-38.04%)
1.84M
(+46.03%)
1.26M
(-10.64%)
1.41M
(+161.11%)
540K
(-70.65%)
1.84M
(-27.84%)
2.55M
(-22.96%)
3.31M
(-3.50%)
3.43M
(-24.78%)
4.56M
(+8.83%)
4.19M
(-27.88%)
5.81M
(-5.53%)
6.15M
(+4.59%)
5.88M
(+11.36%)
5.28M
(+33.67%)
3.95M
(+18.62%)
3.33M
(-6.98%)
3.58M
(+15.48%)
3.10M
(-55.78%)
7.01M
(+180.40%)
2.50M--
Selling General And Administrative
1.68M
(-4.55%)
1.76M
(-4.86%)
1.85M
(0.00%)
1.85M
(+45.67%)
1.27M
(+56.79%)
810K
(-30.17%)
1.16M
(+9.43%)
1.06M
(-17.19%)
1.28M
(-41.55%)
2.19M
(+21.67%)
1.80M
(+1.12%)
1.78M
(+7.23%)
1.66M
(-20.19%)
2.08M
(+13.04%)
1.84M
(+1.10%)
1.82M
(-13.33%)
2.10M
(-11.02%)
2.36M
(+191.36%)
810K
(-6.90%)
870K
(+47.46%)
590K
(-28.05%)
820K
(+74.47%)
470K--
Operating Expenses
2.88M
(-12.20%)
3.28M
(+9.70%)
2.99M
(-18.97%)
3.69M
(+45.85%)
2.53M
(+14.48%)
2.21M
(+30.00%)
1.70M
(-41.38%)
2.90M
(-24.28%)
3.83M
(-30.36%)
5.50M
(+5.36%)
5.22M
(-17.67%)
6.34M
(+8.38%)
5.85M
(-25.86%)
7.89M
(-1.25%)
7.99M
(+3.77%)
7.70M
(+4.48%)
7.37M
(+16.80%)
6.31M
(+52.05%)
4.15M
(-6.74%)
4.45M
(+20.60%)
3.69M
(-52.87%)
7.83M
(+163.64%)
2.97M--
Depreciation And Amortization
40K
(-69.23%)
130K--50K
(-68.75%)
160K--50K
(-68.75%)
160K--50K
(-44.44%)
90K--30K
(-50.00%)
60K--20K
(-66.67%)
60K---
Operating Income
Operating Income
-2.88M
(+6.27%)
-2.71M
(-14.78%)
-3.18M
(-21.48%)
-4.05M
(+50.00%)
-2.70M
(+8.00%)
-2.50M
(+32.98%)
-1.88M
(-38.76%)
-3.07M
(-19.84%)
-3.83M
(-30.36%)
-5.50M
(+5.36%)
-5.22M
(-17.67%)
-6.34M
(+8.38%)
-5.85M
(-25.86%)
-7.89M
(-1.25%)
-7.99M
(+3.77%)
-7.70M
(+4.48%)
-7.37M
(+15.88%)
-6.36M
(-52.47%)
-13.38M
(+138.50%)
-5.61M
(+86.38%)
-3.01M
(-65.44%)
-8.71M
(+47.13%)
-5.92M--
Ebit
-2.88M
(+6.27%)
-2.71M
(-14.78%)
-3.18M
(-21.48%)
-4.05M
(+50.00%)
-2.70M
(+8.00%)
-2.50M
(+32.98%)
-1.88M
(-38.76%)
-3.07M
(-19.84%)
-3.83M
(-30.36%)
-5.50M
(+5.36%)
-5.22M
(-17.67%)
-6.34M
(+8.38%)
-5.85M
(-25.86%)
-7.89M
(-1.25%)
-7.99M
(+3.77%)
-7.70M
(+4.48%)
-7.37M
(+15.88%)
-6.36M
(-52.47%)
-13.38M
(+138.50%)
-5.61M
(+86.38%)
-3.01M
(+5920.00%)
-50.00K
(-99.16%)
-5.92M
(+38.64%)
-4.27M
(-2.73%)
-4.39M
EBITDA
-2.85M
(+8.37%)
-2.63M
(-9.62%)
-2.91M
(-31.69%)
-4.26M
(+60.75%)
-2.65M
(-2.93%)
-2.73M
(+49.18%)
-1.83M
(-32.97%)
-2.73M
(-27.78%)
-3.78M
(-32.38%)
-5.59M
(+9.18%)
-5.12M
(-17.42%)
-6.20M
(+6.71%)
-5.81M
(-47.37%)
-11.04M
(+74.41%)
-6.33M
(+3.60%)
-6.11M
(-16.87%)
-7.35M
(+31.96%)
-5.57M
(-58.40%)
-13.39M
(+111.20%)
-6.34M
(+112.04%)
-2.99M
(+475.00%)
-520.00K
(-90.37%)
-5.40M
(+26.46%)
-4.27M
(-2.73%)
-4.39M
Other Income / Expenses
Interest Expense
--30.00K
(+50.00%)
-20.00K
(-33.33%)
-30.00K
(0.00%)
-30.00K
(0.00%)
-30.00K
(0.00%)
-30.00K
(0.00%)
-30.00K
(+200.00%)
-10.00K
(-66.67%)
-30.00K-------810K
(-7.95%)
880K-740K
(-58.89%)
1.80M
(+181.25%)
640K--
Net Interest Income
-30K
(0.00%)
30K
(0.00%)
30K
(0.00%)
30K
(0.00%)
30K
(0.00%)
30K
(0.00%)
30K
(+200.00%)
10K
(-66.67%)
30K--------810.00K
(-7.95%)
-880.00K--740.00K
(-58.89%)
-1.80M
(+181.25%)
-640.00K--
Other Non Operating Income
60K-30.00K240K-190.00K
(+137.50%)
-80.00K330K-330K-----2.70M
(+73.08%)
1.56M
(0.00%)
1.56M-400.00K220K-360.00K80K-90.00K840K
(+61.54%)
520K--
Net Income
Net Income From Continuing Operations
-2.74M
(+5.38%)
-2.60M
(-10.03%)
-2.89M
(-31.84%)
-4.24M
(+53.07%)
-2.77M
(+12.60%)
-2.46M
(+35.91%)
-1.81M
(-32.96%)
-2.70M
(-29.13%)
-3.81M
(-30.22%)
-5.46M
(+6.64%)
-5.12M
(-17.42%)
-6.20M
(+8.96%)
-5.69M
(-26.77%)
-7.77M
(+22.75%)
-6.33M
(+3.60%)
-6.11M
(-21.47%)
-7.78M
(+35.07%)
-5.76M
(-59.64%)
-14.27M
(+125.08%)
-6.34M
(+64.68%)
-3.85M
(+150.00%)
-1.54M
(-74.50%)
-6.04M
(+41.45%)
-4.27M
(-2.73%)
-4.39M
Net Income
-2.74M
(+5.38%)
-2.60M
(-10.03%)
-2.89M
(-31.84%)
-4.24M
(+53.07%)
-2.77M
(+12.60%)
-2.46M
(+35.91%)
-1.81M
(-32.96%)
-2.70M
(-29.13%)
-3.81M
(-30.22%)
-5.46M
(+6.64%)
-5.12M
(-17.42%)
-6.20M
(+8.96%)
-5.69M
(-26.77%)
-7.77M
(+22.75%)
-6.33M
(+3.60%)
-6.11M
(-21.47%)
-7.78M
(+35.07%)
-5.76M
(-59.64%)
-14.27M
(+125.08%)
-6.34M
(+64.68%)
-3.85M
(+150.00%)
-1.54M
(-74.50%)
-6.04M
(+41.45%)
-4.27M
(-2.73%)
-4.39M
Comprehensive Income Net Of Tax
-2.72M
(-78.38%)
-12.58M
(+339.86%)
-2.86M
(-33.33%)
-4.29M
(+53.21%)
-2.80M
(-74.52%)
-10.99M
(+487.70%)
-1.87M
(-36.18%)
-2.93M
(-22.28%)
-3.77M
(-83.32%)
-22.60M
(+349.30%)
-5.03M
(-19.13%)
-6.22M
(+7.80%)
-5.77M
(-79.14%)
-27.66M
(+258.75%)
-7.71M
(+63.69%)
-4.71M
(-35.03%)
-7.25M
(-75.27%)
-29.32M
(+113.70%)
-13.72M
(+111.08%)
-6.50M
(+86.25%)
-3.49M
(-80.20%)
-17.63M
(+157.37%)
-6.85M--